Cargando…
Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
BACKGROUND: The protease BACE1 (beta-site APP cleaving enzyme) is a major drug target in Alzheimer’s disease. However, BACE1 therapeutic inhibition may cause unwanted adverse effects due to its additional functions in the nervous system, such as in myelination and neuronal connectivity. Additionally...
Autores principales: | Pigoni, Martina, Wanngren, Johanna, Kuhn, Peer-Hendrik, Munro, Kathryn M., Gunnersen, Jenny M., Takeshima, Hiroshi, Feederle, Regina, Voytyuk, Iryna, De Strooper, Bart, Levasseur, Mikail D., Hrupka, Brian J., Müller, Stephan A., Lichtenthaler, Stefan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053352/ https://www.ncbi.nlm.nih.gov/pubmed/27716410 http://dx.doi.org/10.1186/s13024-016-0134-z |
Ejemplares similares
-
Seizure-6 proteins highlight BACE1 functions in neurobiology
por: Pigoni, Martina, et al.
Publicado: (2016) -
BACE inhibitor treatment of mice induces hyperactivity in a Seizure-related gene 6 family dependent manner without altering learning and memory
por: Nash, A., et al.
Publicado: (2021) -
The β-Secretase Substrate Seizure 6–Like Protein (SEZ6L) Controls Motor Functions in Mice
por: Ong-Pålsson, Emma, et al.
Publicado: (2021) -
Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System
por: Munro, Kathryn M., et al.
Publicado: (2016) -
BACE2 distribution in major brain cell types and identification of novel substrates
por: Voytyuk, Iryna, et al.
Publicado: (2018)